Article Versions Notes

Silzle T, Blum S, Kasprzak A, Nachtkamp K, Rudelius M, Hildebrandt B, Götze KS, Gattermann N, Lauseker M, Germing U. The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score. Cancers. 2023; 15(14):3572. https://doi.org/10.3390/cancers15143572

Silzle, Tobias, Sabine Blum, Annika Kasprzak, Kathrin Nachtkamp, Martina Rudelius, Barbara Hildebrandt, Katharina S. Götze, Norbert Gattermann, Michael Lauseker, and Ulrich Germing. 2023. "The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score" Cancers 15, no. 14: 3572. https://doi.org/10.3390/cancers15143572

Silzle, T., Blum, S., Kasprzak, A., Nachtkamp, K., Rudelius, M., Hildebrandt, B., Götze, K. S., Gattermann, N., Lauseker, M., & Germing, U. (2023). The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score. Cancers, 15(14), 3572. https://doi.org/10.3390/cancers15143572